Cyclerion Therapeutics Announces Proposed Merger and Reverse Stock Split

Cyclerion Therapeutics, Inc. filed an 8-K reporting a proposed merger and the anticipated filing and effectiveness of articles of amendment effecting a reverse stock split.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai